PRISCILLA KINESITHERAPIE: what changed
PRISCILLA KINESITHERAPIE
Largest movements
- Cash +€5,226
up €5,226 (+16.0%), from €32,721 to €37,947
mainly Deferred charges and accrued income (+€3,119) and Other debts (+€1,411)
- Deferred charges and accrued income -€3,119
down €3,119 (-100%), from €3,119 to €0
- Other debts +€1,411
up €1,411 (+5.6%), from €25,334 to €26,744
- Profit (loss) carried forward +€624
up €624 (+11.1%), from -€5,630 to -€5,006
- Gross operating margin +€795
up €795 (+51.4%), from €1,547 to €2,342
- Other operating charges +€304
up €304 (+24.0%), from €1,267 to €1,571
- Taxes -€57
down €57 (-44.1%), from €129 to €72
- Financial charges -€38
down €38 (-33.9%), from €114 to €75
Change in the result, 2025 to 2026
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,053 | €37,947 | +€1,895 | +5.3% |
| Current assets | 29/58 | €36,053 | €37,947 | +€1,895 | +5.3% |
| Amounts receivable after more than one year | 29 | €0 | - | = | |
| Other amounts receivable | 291 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €213 | €0 | -€213 | -100% |
| Trade receivables | 40 | €211 | €0 | -€211 | -100% |
| Other amounts receivable | 41 | €1 | €0 | -€1 | -100% |
| Cash at bank and in hand | 54/58 | €32,721 | €37,947 | +€5,226 | +16.0% |
| Deferred charges and accrued income | 490/1 | €3,119 | €0 | -€3,119 | -100% |
| Total equity and liabilities | 10/49 | €36,053 | €37,947 | +€1,895 | +5.3% |
| Equity | 10/15 | €9,370 | €9,994 | +€624 | +6.7% |
| Contributions | 10/11 | €15,000 | €15,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€5,630 | -€5,006 | +€624 | +11.1% |
| Amounts payable | 17/49 | €26,683 | €27,953 | +€1,270 | +4.8% |
| Amounts payable within one year | 42/48 | €25,545 | €26,815 | +€1,270 | +5.0% |
| Trade debts | 44 | €211 | €0 | -€211 | -100% |
| Suppliers | 440/4 | €211 | €0 | -€211 | -100% |
| Taxes, remuneration and social security | 45 | €0 | €71 | +€71 | |
| Taxes | 450/3 | €0 | €71 | +€71 | |
| Other amounts payable | 47/48 | €25,334 | €26,744 | +€1,411 | +5.6% |
| Accrued charges and deferred income | 492/3 | €1,138 | €1,138 | = | 0.0% |
| Other operating charges | 640/8 | €1,267 | €1,571 | +€304 | +24.0% |
| Gross operating margin | 9900 | €1,547 | €2,342 | +€795 | +51.4% |
| Operating profit (loss) | 9901 | €280 | €772 | +€491 | +175% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €114 | €75 | -€38 | -33.9% |
| Recurring financial charges | 65 | €114 | €75 | -€38 | -33.9% |
| Profit (loss) for the period before taxes | 9903 | €167 | €697 | +€530 | +318% |
| Income taxes | 67/77 | €129 | €72 | -€57 | -44.1% |
| Profit (loss) for the period | 9904 | €38 | €624 | +€587 | +1,549% |
| Profit (loss) for the period to be appropriated | 9905 | €38 | €624 | +€587 | +1,549% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2025 and 30 June 2026. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.